Effects of tolerogenic dendritic cells generated by siRNA-mediated RelB silencing on immune defense and surveillance functions of T cells

Cellular Immunology

Volumn 282, Issue 1, 2013, Pages 28-37

  Luo, Lei ^a   Sun, Zhaolin ^a   Fang, Qian ^a   Huang, Shan ^a   Bai, Xiaoling ^a   Luo, Guangheng ^a  

^a GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Dendritic cells; Hyporesponsiveness; Immune defense; Immune surveillance; RelB

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELB; TUMOR ANTIGEN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENE SILENCING; IMMUNITY; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNE TOLERANCE; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICRORNAS; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELB;

EID: 84877353367     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.03.004     Document Type: Article

References (37)

1. Sayegh M.H., Carpenter C.B. Transplantation 50 years later - progress, challenges, and promises. N. Eng. J. Med. 2004, 351(26):2761-2766.
2. Lechler R.I., Sykes M., Thomson A.W., Turka L.A. Organ transplantation - how much of the promise has been realized?. Nat. Med. 2005, 11(6):605-613.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
4. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.
5. Morelli A.E., Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007, 7(8):610-621.
6. Zhang Y., Yang H., Xiao B., Wu M., Zhou W., Li J., et al. Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis. Mol. Immunol. 2009, 46(4):657-667.
7. Zhang M., Tang H., Guo Z., An H., Zhu X., Song W., et al. Splenic stroma drives mature dendritic cells to differentiate in to regulatory dendritic cells. Nat. Immunol. 2004, 5(11):1124-1133.
8. Li M., Zhang X., Zheng X., Lian D., Zhang Z.X., Ge W., et al. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J. Immunol. 2007, 178(9):5480-5487.
9. Sun W., Wang Q., Zhang L., Liu Y., Zhang M., Wang C., et al. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin. Transplantation 2003, 76(9):1351-1359.
10. Liang X., Lu L., Chen Z., Vickers T., Zhang H., Fung J.J., et al. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003, 76(4):721-729.
11. Turnquist H.R., Raimondi G., Zahorchak A.F., Fischer R.T., Wang Z., Thomson A.W. Rapamycin-conditioned dendritic cells are poor stimulators of allogenic CD4+ cells, but enrich for antigen-specific Foxp3+T regulatory cells and promote organ transplant tolerance. J. Immunol. 2007, 178(11):7018-7031.
12. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 1998, 188(11):2175-2180.
13. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3kinase, p38 SAP kinase, and NF- kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocytederived dendritic cells. Blood 2000, 96(3):1039-1046.
14. Yoshimura S., Bondeson J., Foxwell B.M., Brennan F.M., Feldmann M. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 2001, 13(5):675-683.
15. Giannoukakis N., Bonham C.A., Qian S., Chen Z., Peng L., Harnaha J., et al. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol. Ther. 2000, 1(5 Pt 1):430-437.
16. Burkly L., Hession C., Ogata L., Reilly C., Marconi L.A., Olson D., et al. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373(6514):531-536.
17. Weih F., Carrasco D., Durham S.K., Barton D.S., Rizzo C.A., Ryseck R.P., et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF- kappa B/Rel family. Cell 1995, 80(2):331-340.
18. Wu L., D'Amico A., Winkel K.D., Suter M., Lo D., Shortman K. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 1998, 9(6):839-847.
19. Qiu T., Zhu H.C., Liu X.H., Dong W.C., Weng X.D., Hu C.H., et al. Lentiviral-mediated shRNA against RelB induces the generation of tolerogenic dendritic cells. Int. Immunopharmacol. 2012, 12(3):501-509.
20. Zhu H.C., Qiu T., Liu X.H., Dong W.C., Weng X.D., Hu C.H., et al. Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection. Cell Immunol. 2012, 274(1-2):12-18.
21. Beriou G., Moreau A., Cuturi M.C. Tolerogenic dendritic cells: applications for solid organ transplantation. Curr. Opin. Organ Transplant. 2012, 17(1):42-47.
22. Zhao Y., Li X.C. Transplant tolerance. is it really free of concerns?. Trends Immunol. 2007, 28(9):376-377.
23. Ballet C., Roussey-Kesler G., Aubin J.T., Brouard S., Giral M., Miqueu P., et al. Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am. J. Transplant. 2006, 6(11):2796-2801.
24. Luo L., Li C., Wu W., Lu J., Shan J., Li S., et al. Dendritic cells transduced with lentiviral vector targeting RelB gene using RNA interference induce hyporesponsiveness in memory CD4(+) T cells and naïve CD4(+) T cells. Cell Immunol. 2012, 273(1):85-93.
25. Levy G.A. Progress in transplantation. Ther. Drug Monit. 2010, 32(3):246-249.
26. Lee M.K., Moore D.J., Jarrett B.P., Lian M.M., Deng S., Huang X., et al. Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 2004, 172(11):6539-6544.
27. Zhang X., Li M., Lian D., Zheng X., Zhang Z.X., Ichim T.E., et al. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin. Immunol. 2008, 127(3):313-321.
28. Nouri-Shirazi M., Guinet E. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation 2002, 74(7):1035-1044.
29. Lu L., Li W., Zhong C., Qian S., Fung J.J., Thomson A.W., et al. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation 1999, 68(6):747-757.
30. Christensen H.R., Frøkiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002, 168(1):171-178.
31. Suciu-Foca N., Berloco P., Cortesini R. Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases. Hum. Immunol. 2009, 70(5):277-280.
32. Lykken E.A., Li Q.J. MicroRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells. Immunol. Res. 2011, 49(1-3):87-96.
33. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Ann. Rev. Biochem. 2010, 79:351-379.
34. Li Q.J., Chau J., Ebert P.J., Sylvester G., Min H., Liu G., et al. MiR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129(1):147-161.
35. Becher B., Blain M., Giacomini P.S., Antel J.P. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J. Immunol. 1999, 162(2):684-688.
36. Voisine C., Hubert F.X., Trinité B., Heslan M., Josien R. Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity. J. Immunol. 2002, 169(5):2284-2291.
37. Banerjee A., Schambach F., DeJong C.S., Hammond S.M., Reiner S.L. Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur. J. Immunol. 2010, 40(1):225-231.